Latest Diabetic retinopathy Stories
TARRYTOWN, N.Y., Jan. 23, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
Diopsys® NOVA ERG and VEP protocols along with tests looking at optic nerve structure can be used for evaluation of glaucoma progression Pine Brook, NJ
ATLANTA, Jan. 14, 2015 /PRNewswire/ -- Alimera Sciences, Inc.
Mediaplanet announces distribution of its first cross-platform edition of Vision and Hearing, educating Canadians and providing proactive
GAITHERSBURG, Md., Dec.
ATLANTA, Dec. 1, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
Treatment of Visual Impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) and Diabetic Macular Edema (DME) are the Second and Third Indications for Eylea(®) in Canada
TARRYTOWN, N.Y., Dec. 1, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S.
TARRYTOWN, N.Y., Nov. 18, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd.
- totally perplexed and mixed up.